期刊文献+
共找到202篇文章
< 1 2 11 >
每页显示 20 50 100
Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment:a radioimmunoconjugate for hepatocellular carcinoma imaging 被引量:13
1
作者 Hui Jie Bian Zhi Nan Chen Jing Lan Deng 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第3期348-352,共5页
AIM To directly radiolabel an anti-hepatomamAb fragment HAb18 F(ab’)<sub>2</sub> with <sup>99m</sup>Tc bystannous-reduced method,and assess thestability,biodistribution and radioimmun-oimag... AIM To directly radiolabel an anti-hepatomamAb fragment HAb18 F(ab’)<sub>2</sub> with <sup>99m</sup>Tc bystannous-reduced method,and assess thestability,biodistribution and radioimmun-oimaging(RⅡ).METHODS Immunoreactive fraction wasdetermined according to Lindmo’s method.Ellman’s reagent was used to determine thenumber of thiols in the reduced F(ab’)<sub>2</sub>.Labelingefficiency and homogeneity were measured bypaper chromatography,sodium dodecylsulphatepolyacrylamide gel electrophoresis(SDS-PAGE)and autoradiography.Challenge assay involvedthe incubation of aliquots of labeled antibody inethylenediaminetetraacetate( EDTA )and L-cysteine(L-cys)solutions with different molarratio at 37℃ for 1h,respectively.Investigationsin vivo utilized nude mice bearing humanhepatocellular carcinoma(HHCC)xenograftswith gamma camera imaging and tissuebiodistribution studies at regular intervals.RESULTS The labeling procedure was finishedwithin 1.5 h compared with the'pretinning'method which would take at least 21h.In vitrostudies demonstrated that the radiolabeled mAbfragment was homogeneous and retained itsimmunoreactivity.Challenge studies indicatedthat <sup>99m</sup>Tc-labeled HAb18 F(ab’)<sub>2</sub> in EDTA is morestable than in L-cys.Imaging and biodistribution showed a significant tumor uptake at 24 h post-injection of <sup>99m</sup>Tc-labeled HAb18 F(ab’)<sub>2</sub>.Theblood,kidney,liver and tumor uptakes at 24hwere 0.56±0.09,56.45±11.36,1.43±0.27 and6.57±3.01(%ID/g),respectively.CONCLUSION <sup>99m</sup>Tc-HAb18 F(ab’)<sub>2</sub> conjugateprepared by this direct method appears to be aneffective way to detect hepatoma in nude micemodel. 展开更多
关键词 ANTIBODY monoclonal ANTIBODY FRAGMENTS technetium-99m hepatocellular carcinoma liver neoplasms RADIOIMMUNOIMAGING
下载PDF
Expression of human yrdC gene promotes proliferation of gastric carcinoma cells 被引量:1
2
作者 Tingsong Yang Xiaojun Shen +6 位作者 Jianwei Bi Shengdong Huang Guo Wei Hongliang Zhu Xiaojun Tang Yang Yuan Dejun Gong 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第8期433-437,共5页
Objective: The aim of the research was to study the function of human yrdC gene in the gastric carcinoma cells. Methods: Human yrdC gene was isolated from human spleen tissue by RT-PCR. Anti-human yrdC monoclonal an... Objective: The aim of the research was to study the function of human yrdC gene in the gastric carcinoma cells. Methods: Human yrdC gene was isolated from human spleen tissue by RT-PCR. Anti-human yrdC monoclonal antibody was prepared by hybridoma cell technique. Recombinant adenovirus Ad.yrdC carrying yrdC gene was constructed by using the AdEasy adenoviral vector system. Recombinant adenovirus Ad.yrdCshRNA mediated yrdCshRNA was prepared by RNA interference technology. Gastric adenocarcinoma BGC-823 cells of moderate differentiation were transfected and absorbance of the transfected cells was calculated at 490 nm by methyl thiazolyl tetrazolium (MTT) method. Results: A value of the transfected Ad.yrdC group was significantly greater than that of the non-transfected and transfected Ad.Null groups, and A value of Ad.yrdCshRNA group was significantly lower than that of the non-transfected and transfected Ad.Null groups. Conclusion: Expression of yrdC gene has a function of promoting the proliferation of gastric carcinoma cells. 展开更多
关键词 human yrdC gene gastric carcinoma monoclonal antibody recombinant adenovirus
下载PDF
STUDY ON METASTASIS ASSOCIATED GENE SCREENED BY MONOCLONAL ANTIBODY HIL
3
作者 齐藤平 张沛基 +3 位作者 魏曙光 陈东 李仁 王吾如 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1996年第1期37-41,共5页
The cDNA expression libraries derived from a highly metastatic cell subline Anip-973 and from its parental cell line, low metastatic AGZY-83a were screened by monoclonal antibodies (MoAbs) seperately against these two... The cDNA expression libraries derived from a highly metastatic cell subline Anip-973 and from its parental cell line, low metastatic AGZY-83a were screened by monoclonal antibodies (MoAbs) seperately against these two cell lines. A positive clone(H4-D) from the Anip-973 cDNA library was isolated and its nucleotide sequence was determined. This clone contained 978 bp with an open reading frame of 318 bp encoding a polypeptide consisting of 106 amino acids. The H4-D cDNA sequence showed 85% homology with a human propionyl-CoA carboxylase α-chain. In Western bloting analysis, the MoAb H4 recognized 2 bands(15 KDa and 27 KDa) of Anip-973 cell membrane Protein. The mRNA expression of H4-D was higher in AniP-973 cells than that in AGZY-83a cells. The metastatic Potential of Anip-973 cells was markedly decreased after being pretreated with MoAb H4. The above findings indicated that H4-D has a certain relationship with the metastatic phenotype of AniP-973 cells. 展开更多
关键词 Neoplasm metastasis gene monoclonal antibody cDNA cloning.
下载PDF
Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F( ab′ )_2 fragment and staphylococcal enterotoxin A 被引量:20
4
作者 Lian Jun Yang Yan Fang Sui Zhi Nan Chen Department of Pathology, Fourth Military Medical University. Xi’an 710032, Shaanxi Province, China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期216-221,共6页
AIM To prepare the conjugate of staphylococcal enterotoxin A (SEA) protein which is a bacterial SAg and the F(ab')2 fragment of mAb HAbl8 against human hepatocellular carcinoma (HCC), and identify its activity in ... AIM To prepare the conjugate of staphylococcal enterotoxin A (SEA) protein which is a bacterial SAg and the F(ab')2 fragment of mAb HAbl8 against human hepatocellular carcinoma (HCC), and identify its activity in order to use SAg in the targeting therapy of HCC.METHODS MAb HAbl8 was extracted from the abdominal dropsy of Balb/ c mice, and was purified through chromatography column SP-40HR with Fast protein liquid chromatography (FPLC) system. The F(ab')2 fragment of mAb HAb18 was prepared by papainic digestion method. The conjugate of mAb HAb18 F(ab')2fragment and SEA was prepared with chemical conjugating reagent N-succinimidyl-3-( 2-pyridyldithio) propionate (SPDP) and purified through chromatography column Superose 12with FPLC system. The molecular mass and purity of each collected peak were identified with SDS-PAGE assay. The protein content was assayed by Lowry's method. The antibody activity of HAb18 F (ab')2 against HCC in the conjugate was identified by indirect immunocytochemical ABC method, and the activity of SEA in the conjugate to activate peripheral blood mononuclear cells (PBMC) was identified with MTT assay.RESULTS The lgG mAb HAb18 was extracted,and purified successfully. Immunocytochemical staining demonstrated that it reacted with most of HHCC cells of human HCC cell line. There were two peaks in the process of purification of the prepared HAb18 F(ab)2-SEA conjugate. SDS-PAGE assay demonstrated that the molecular mass of the first peak was about 130 ku, and the second peak was the mixture of about 45 ku and a little 100 ku proteins. The immunocytochemical staining was similar in HAb18 F (ab ')2-SEAconjugate and HAb18 F (ab ')2, i.e., thecytoplasm and/or cell membranes of most HHCC cells were positively stained. The MTT assay showed that the optical absorbance (A) value at 490 nm of HAb18 F (ab')2-SEA conjugate was 0.182 ± 0.012, that of negative control was 0.033± 0.009, and there was significant difference between them ( P < 0.05).CONCLUSION SPDP is a good proteinconjugating reagent and can be used in preparing protein conjugate. The conjugate of mAb HAb18F(ab')2 fragment and SEA protein was preparedsuccessfully in present study and can be used in the experimental study of HCC targeting therapy with the conjugate of SAg and anti-HCC mAbs or their fragments. 展开更多
关键词 carcinoma hepatocellular/immunology liver neoplasms/immunology SUPERANTIGENS ENTEROTOXINS antibodies monoclonal
下载PDF
Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3 被引量:13
5
作者 Feng-Tian He Rong-Fen Li Yun-Sheng Kang Yan Zhang,Department of Biochemistry & Molecular Biology,Third Military Medical University,Chongqing 400038,China Yong-Zhan Nie Bao-Jun Chen Tai-Dong Qiao Dai-Ming Fan,Institute of Digestive Disease,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,Shaanxi Province,China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第2期258-262,共5页
AIM: To generate soluble single chain variable fragments (ScFv) of monoclonal antibody MC3 recognizing colorectal and gastric carcinomas. METHODS: mRNA was isolated from the hybridoma cell line producing MC3 and the D... AIM: To generate soluble single chain variable fragments (ScFv) of monoclonal antibody MC3 recognizing colorectal and gastric carcinomas. METHODS: mRNA was isolated from the hybridoma cell line producing MC3 and the DNAs encoding variable domains of heavy and light chains (VH and VL) of the antibody were amplified separately by RT-PCR and assembled into ScFv DNA with a linker DNA. The ScFv DNA was ligated into the phagemid vector pCANTAB5E and the ligated sample was transformed into E.coli TG1.The transformed cells were infected with M13KO7 helper phage to yield recombinant phages. After two rounds of panning with gastric carcinoma cell line AGS highly expressing MC3-binding antigen, the phage clones displaying ScFv fragments of the antibody were selected by ELISA. 4 phage clones showing strong signal in ELISA were used to infect E.coli HB2151 to express soluble ScFvs. The soluble ScFvs were identified by Dot blot and Western blot, and their antigen-binding activity was assayed by ELISA. The VH and VL DNAs of the ScFv DNA derived from phage clone 19 were sequenced. RESULTS: The VH,VL and ScFv DNAs were about 340 bp, 320 bp and 750 bp respectively. After two rounds of panning to the recombinant phages, 18 antigen-positive phage clones were selected from 30 preselected phage clones by ELISA. All the soluble ScFvs derived from the 4 out of the 18 antigen-positive phage clones were about M(r)32000 and concentrated in periplasmatic space under the given culture condition. The soluble ScFvs could bind the antigen, and they shared the same binding site with MC3. The sequences of the VH and VL DNAs of the MC3 ScFv showed that the variable antibody genes belonged to the IgG1 subgroup,kappa-type. CONCLUSION: The soluble ScFv of MC3 is successfully produced, which not only provides a possible novel targeting vehicle for in vivo and in vitro study on associated cancers, but also offers the antibody a stable genetic source. 展开更多
关键词 Animals antibodies monoclonal Base Sequence carcinoma Colorectal neoplasms Enzyme-Linked Immunosorbent Assay Humans Immunoglobulin Fragments Immunoglobulin Variable Region Mice Molecular Sequence Data Recombinant Proteins Stomach neoplasms Tumor Cells Cultured
下载PDF
Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity 被引量:13
6
作者 SunHZ WuSF 《Cell Research》 SCIE CAS CSCD 2001年第2期107-115,共9页
A major problem which is poorly understood in the management of bladder cancer is low sensitivity to chemotherapy and high recurrence after transurethral resection. Insulin-like growth factor 1 receptor (IGF-1R) signa... A major problem which is poorly understood in the management of bladder cancer is low sensitivity to chemotherapy and high recurrence after transurethral resection. Insulin-like growth factor 1 receptor (IGF-1R) signaling plays a very important role in progression, invasion and metastasis of bladder cancer cells. In this study, we investigated whether IGF-1R was involved in the growth stimulating activity and drug resistance of bladder cancer cells. The results showed: The mRNAs of IGF-1, IGF-2 and IGF-1R were strongly expressed in serum-free cultured T24 cell line, whereas normal urothelial cells did not express these factors/receptors or only in trace levels; T24 cell responded far better to growth stimulation by IGF-1 than did normal urothelial cells; blockage of IGF1R by antisense oligodeoxynucleotide (ODN) significantly inhibited the growth of T24 cell and enhanced sensitivity and apoptosis of T24 cells to mitomycin (MMC). These results suggested that blockage of IGF-IR signaling might potentially contribute to the treatment of bladder cancer cells which are insensitive to chemotherapy. 展开更多
关键词 Antibiotics Antineoplastic Apoptosis Autocrine Communication bladder neoplasms carcinoma Transitional Cell Cell Division CYTOTOXINS Drug Resistance Neoplasm gene Expression Regulation Neoplastic gene Targeting Humans Insulin-Like Growth Factor I Insulin-Like Growth Factor II Microscopy Electron MITOMYCIN Oligodeoxyribonucleotides Antisense Protein Synthesis Inhibitors RNA Messenger Receptor IGF Type 1 Signal Transduction Tumor Cells Cultured
下载PDF
Cloning of 3H11 mAb variable region gene and expression of 3H11 human-mouse chimeric light chain 被引量:3
7
作者 LI Jing WANG Yan +3 位作者 LI Quan-Xi WANG Ya-Ming XU Jian-Jun DONG Zhi-Wei 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第1期46-49,共4页
IM To clone mouse antihuman gastric cancer mAb(3H11) variable genes and to construct 3H11 humanmouse chimeric antibody.METHODS The entire VH and VL genes of antigastric cancer mAb 3H11 were cloned by RTPCR method ... IM To clone mouse antihuman gastric cancer mAb(3H11) variable genes and to construct 3H11 humanmouse chimeric antibody.METHODS The entire VH and VL genes of antigastric cancer mAb 3H11 were cloned by RTPCR method from 3H11 hybridoma cells, using 5′ primers for leader sequences. The 3H11 VL gene was then inserted into humanmouse chimeric light chain expression vector and transfected into murine Sp2/0 myeloma cells.RESULTS DNA sequence analysis indicated that the cloned genes included the whole leader sequences and the mature Ig variable region encoding sequences. After gene transfection, transient expression of chimeric light chain protein was detected.CONCLUSION DNA sequences and transient expression indicated that the cloned gene was functional. This work laid basis for constructing 3H11 humanmouse chimeric antibody in the future.. 展开更多
关键词 gene expression stomach neoplasms antibodies monoclonal chimeric antibody
全文增补中
替雷利珠单抗联合舒尼替尼治疗转移性肾癌的临床疗效及生存分析
8
作者 王梦婕 郭小芳 《医学临床研究》 CAS 2024年第10期1526-1529,共4页
【目的】探讨替雷利珠单抗联合舒尼替尼治疗转移性肾癌的临床疗效及生存结局。【方法】将42例转移性肾癌患者随机分为观察组和对照组,每组21例。观察组口服舒尼替尼联合静脉滴注替雷利珠单抗治疗,对照组口服舒尼替尼联合静脉滴注生理盐... 【目的】探讨替雷利珠单抗联合舒尼替尼治疗转移性肾癌的临床疗效及生存结局。【方法】将42例转移性肾癌患者随机分为观察组和对照组,每组21例。观察组口服舒尼替尼联合静脉滴注替雷利珠单抗治疗,对照组口服舒尼替尼联合静脉滴注生理盐水治疗。治疗6个周期后,比较两组患者的疗效、不良反应发生情况及生存预后;比较两组患者治疗前后的CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)、基质金属蛋白酶2(MMP-2)、血管内皮生长因子(VEGF)、组织金属蛋白酶抑制剂-1(TIMP-1)水平。【结果】观察组疾病控制率为90.48%,高于对照组的61.90%,且差异有统计学意义(P<0.05)。治疗后,两组CD3^(+)、CD4^(+)及CD4^(+)/CD8^(+)较治疗前均升高,且观察组高于对照组(P<0.05)。治疗后,两组MMP-2、VEGF及TIMP-1较治疗前均降低,且观察组低于对照组(P<0.05)。两组患者的不良反应发生率比较,差异无统计学意义(P>0.05)。对照组和观察组患者的中位无进展生存期(PFS)分别为11个月、15个月,两组中位PFS曲线比较,差异有统计学意义(P<0.05)。【结论】替雷利珠单抗联合舒尼替尼治疗转移性肾癌的疗效确切且安全性良好。 展开更多
关键词 肾细胞/药物疗法 肿瘤转移 抗体 单克隆/治疗应用 舒尼替尼/治疗应用 治疗结果
下载PDF
抗人膀胱癌人-鼠嵌合抗体真核表达载体的构建和表达 被引量:9
9
作者 白银 王琰 +3 位作者 周丽君 黄啸 丁义 俞莉章 《北京大学学报(医学版)》 CAS CSCD 北大核心 2001年第5期402-406,共5页
目的 :构建嵌合型抗人膀胱癌抗体的真核表达载体 ,并实现其真核表达。方法 :从杂交瘤细胞中克隆得到鼠源单抗的可变区基因 ,插入嵌合抗体IgG1真核表达载体pDHL中 ,转染CHO细胞 ,实现其真核表达 ,并对抗人膀胱癌人 鼠嵌合抗体的功能进行... 目的 :构建嵌合型抗人膀胱癌抗体的真核表达载体 ,并实现其真核表达。方法 :从杂交瘤细胞中克隆得到鼠源单抗的可变区基因 ,插入嵌合抗体IgG1真核表达载体pDHL中 ,转染CHO细胞 ,实现其真核表达 ,并对抗人膀胱癌人 鼠嵌合抗体的功能进行初步鉴定。结果 :成功构建抗人膀胱癌人 鼠嵌合抗体真核表达载体 ,并实现其真核表达。初步的功能鉴定表明抗人膀胱癌人 鼠嵌合抗体具有较好的特异性和亲合力。结论 :构建的抗人膀胱癌人 鼠嵌合抗体真核表达载体在真核细胞内得到表达 ,且其功能较为理想。 展开更多
关键词 人-鼠嵌合抗体 真核表达 单克隆抗体 药物载体 膀胱肿瘤 治疗 膀胱癌
下载PDF
膀胱癌EJ细胞的CD44异常糖基化及其单抗KMP1的生物学功能研究 被引量:4
10
作者 丁明霞 李翀 +3 位作者 左毅刚 詹辉 范祖森 王剑松 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第13期759-762,共4页
目的:研究EJ细胞单抗KMPl的结合抗原CD44的变化和KMPl对EJ细胞生物学功能的影响。方法:采用人膀胱癌EJ细胞株免疫BALB/c小鼠,获得单抗KMPl,免疫荧光检测KMPl的亲和性、结合部位及效价。流式细胞检测KMPl对膀胱癌细胞的特异性。免疫组化... 目的:研究EJ细胞单抗KMPl的结合抗原CD44的变化和KMPl对EJ细胞生物学功能的影响。方法:采用人膀胱癌EJ细胞株免疫BALB/c小鼠,获得单抗KMPl,免疫荧光检测KMPl的亲和性、结合部位及效价。流式细胞检测KMPl对膀胱癌细胞的特异性。免疫组化检测对膀胱癌组织的特异性。亲和层析分离纯化特异性抗原,检测抗原的氨基酸序列。糖基转化酶抑制剂和过碘酸氧化后分析抗原决定簇的理化性质改变。软琼脂培养克隆形成实验和细胞划痕实验检测KMPl对EJ细胞株的增殖和迁移功能的影响。结果:获得的单抗KMPl是IgGl,能与EJ、BIU-87、T24膀胱癌细胞和膀胱癌组织特异性结合,而与Lovo、HeLa、K562、HepC2、Jurkat、293、HCV29、人的红细胞和白细胞无结合性,也不能结合正常膀胱黏膜。其结合EJ细胞的抗原是异常糖基化的CD44,糖基转化酶抑制剂BC作用EJ细胞7d,KMPl对EJ细胞结合性降低,过碘酸氧化后Western blot显示KMPl对CD44结合性降低,软琼脂培养克隆形成实验和细胞划痕实验结果示KMPl还能减弱EJ细胞的增殖和迁移功能。结论:膀胱癌的高复发性、易转移可能与出现异常糖基化的CD44高表达具有一定的相关性,KMPl可结合异常糖基化的CD44,并抑制EJ细胞的增殖和迁移。 展开更多
关键词 膀胱癌 EJ细胞 单克隆抗体 CD44 糖基化
下载PDF
^(99)Tc^m-抗人膀胱癌-人鼠嵌合抗体在荷人膀胱癌裸鼠的放射免疫显像 被引量:4
11
作者 张春丽 白银 +3 位作者 王荣福 付占立 丁义 俞莉章 《中华核医学杂志》 CAS CSCD 北大核心 2003年第4期212-214,共3页
目的 研究99Tcm 抗人膀胱癌人 鼠嵌合抗体ch BDI对膀胱癌细胞的体外结合性能、在荷人膀胱癌裸鼠中的体内分布及对肿瘤的靶向定位性能。方法 用改进的Schwarz方法进行99Tcm 标记 ,经SephadexG 5 0柱分离纯化。用纸层析法测定标记率与... 目的 研究99Tcm 抗人膀胱癌人 鼠嵌合抗体ch BDI对膀胱癌细胞的体外结合性能、在荷人膀胱癌裸鼠中的体内分布及对肿瘤的靶向定位性能。方法 用改进的Schwarz方法进行99Tcm 标记 ,经SephadexG 5 0柱分离纯化。用纸层析法测定标记率与放化纯 ;用Lindmo的方法测定免疫活性分数 ;用Scatchard作图法求得亲和常数。荷人膀胱癌裸鼠静脉注射99Tcm ch BDI 11.1MBq(30 μg) ,分别于 2、6、2 0及 2 4h行放射免疫显像。用感兴趣区 (ROI)技术获得全身和肿瘤放射性计数及肿瘤与对侧正常组织 (T NT)的放射性比值。 2 4h显像后处死裸鼠 ,测定体内放射性分布 ,计算每克组织百分注射剂量率 (%ID g)及T NT比值。结果 99Tcm ch BDI标记率为 (6 6 .5± 7.3) % ,放化纯 >90 % ,免疫活性分数为 76 % ,亲和常数为 3.5 6× 10 9L mol。荷人膀胱癌裸鼠放射免疫显像结果示 ,静脉注射后 6h肿瘤显影清晰 ,随时间延长更清晰。全身放射性计数随时间延长迅速降低 ,肿瘤放射性计数下降缓慢 ,T NT比值随时间增高。荷瘤裸鼠体内分布结果示 ,静脉注射后 2 4h肿瘤 %ID g为 17.4 ,除肾脏外 ,肿瘤与其他正常组织有很高的T NT比值 ,与脑、肌肉、小肠壁、骨骼及心壁的T NT比值分别为 136 .0、5 5 .1、39.3、2 9.7及 2 7 9。结论 ch BDI具有良? 展开更多
关键词 膀胱癌 ^99TC^M 药代动力学 抗人膀胱癌人-鼠嵌合抗体 ch-BDI 诊断 治疗
下载PDF
膀胱移行上皮癌中P16蛋白的表达意义 被引量:7
12
作者 陈强 王新生 +1 位作者 李玉军 申东亮 《中国肿瘤临床》 CAS CSCD 北大核心 1997年第4期272-275,共4页
采用免疫组织化学LSAB法对68例膀胱移行上皮癌标本中的抑癌基因p16表达产物进行检测,29例显示表达阳性,且阳性表达率在恶性度低、浅表性和未复发膀胱肿瘤中较高,Ⅰ级与Ⅱ级、Ⅰ级与Ⅲ级、Tis~T1与T2~T4、及复发与未复发比较均有显... 采用免疫组织化学LSAB法对68例膀胱移行上皮癌标本中的抑癌基因p16表达产物进行检测,29例显示表达阳性,且阳性表达率在恶性度低、浅表性和未复发膀胱肿瘤中较高,Ⅰ级与Ⅱ级、Ⅰ级与Ⅲ级、Tis~T1与T2~T4、及复发与未复发比较均有显著性差异(P<0.05)。表明p16蛋白表达与膀胱移行上皮癌的分化程度、浸润深度及预后有关。 展开更多
关键词 膀胱肿瘤 移行细胞癌 免疫组织化学 P16蛋白
下载PDF
人端粒酶逆转录酶启动子调控腺病毒介导胸苷激酶基因治疗人膀胱癌的动物实验研究 被引量:5
13
作者 连文峰 林向阳 +6 位作者 张素英 王春仙 杨永安 于洋 宫香宇 陈艳军 张敏 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第18期1058-1061,共4页
目的:探讨带有人端粒酶逆转录酶(hTERT)启动子驱动单纯疱疹病毒胸腺嘧啶激酶(HSV-tk)基因的重组腺病毒Ad-hTERT-HSV-tk结合无毒的环氧鸟苷(GCV)对人膀胱癌的治疗作用。方法:建立人膀胱癌细胞株253JBALB/C裸小鼠移植瘤模型,采用Ad-hTERT-... 目的:探讨带有人端粒酶逆转录酶(hTERT)启动子驱动单纯疱疹病毒胸腺嘧啶激酶(HSV-tk)基因的重组腺病毒Ad-hTERT-HSV-tk结合无毒的环氧鸟苷(GCV)对人膀胱癌的治疗作用。方法:建立人膀胱癌细胞株253JBALB/C裸小鼠移植瘤模型,采用Ad-hTERT-HSV-tk裸鼠尾静脉注射,腹腔注射GCV治疗并观察结果。通过常规病理切片观察肿瘤破坏情况及安全性;通过TUNEL染色进一步观察肿瘤的凋亡情况,免疫组化法测定增值细胞核抗原(PCNA)。结果:Ad-hTERT-HSV-tk/GCV治疗组,显示出明显的肿瘤抑制作用,其肿瘤体积、重量显著低于各对照组(P<0.05),抑瘤率明显。Ad-hTERT-HSV-tk/GCV治疗组凋亡指数高于其它各组,而增殖指数却明显低于其它各组。结论:Ad-hTERT-HSV-tk/GCV系统对裸鼠移植瘤的生长有明显抑制作用,可以靶向性转入人膀胱癌细胞,治疗效果显著。 展开更多
关键词 膀胱肿瘤 单纯疱疹病毒胸腺嘧啶激酶基因 腺病毒 人端粒酶逆转录酶启动子
下载PDF
抗小细胞肺癌单克隆抗体2F_7F(ab′)_2片段的肺癌放射免疫显像 被引量:4
14
作者 苗积生 潘惠忠 +7 位作者 刘进军 吴吉勇 沈毅 林祥通 刘永昌 薛方平 左传涛 史德刚 《中华核医学杂志》 CAS CSCD 北大核心 2002年第5期288-290,共3页
目的 探讨抗小细胞肺癌单克隆抗体99Tcm 2F7F(ab′) 2 放射免疫显像对肺癌诊断的可行性及用药安全性。方法  1 8例肺癌患者静脉注射99Tcm 2F7F(ab′) 2 1~ 2mg约 1 1 1 0MBq ,7~ 8h后行胸部平面前后位及断层显像 ,2 4h再行平面显像... 目的 探讨抗小细胞肺癌单克隆抗体99Tcm 2F7F(ab′) 2 放射免疫显像对肺癌诊断的可行性及用药安全性。方法  1 8例肺癌患者静脉注射99Tcm 2F7F(ab′) 2 1~ 2mg约 1 1 1 0MBq ,7~ 8h后行胸部平面前后位及断层显像 ,2 4h再行平面显像。显像结果与X线胸片对照 ,以病灶区与正常对照区的计数比 (T/N) >1 .2为阳性。结果  1 8例患者从注药到显像结束以及随后的随访均未发现任何不良反应。未经治疗或正在化疗的小细胞肺癌患者 9例显像均呈阳性 ;化疗超过 1 0d或多次化疗者计 5例 ,4例显像阳性 ,临床均为治疗效果较差者 ,余 1例显像阴性 ,治疗效果好。 2例腺癌、1例鳞癌显像阴性 ,另 1例腺癌显像阳性。 2 4hT/N比值比 7~ 8h大。结论 99Tcm 2F7F(ab′) 2 显像阳性率高 ,无不良反应。 展开更多
关键词 小细胞肺癌 单克隆抗体 放射免疫显像 诊断
下载PDF
PGGT、PGGT单克隆抗体和GGT mRNA表达在胰头癌诊断中的价值 被引量:5
15
作者 陈玉泉 王志伟 +3 位作者 沈洪薰 江春平 芮理 江颖 《肝胆胰外科杂志》 CAS 2002年第1期20-22,共3页
目的 :探讨PGGT、PGGT单克隆抗体和GGTmRNA表达在胰头癌诊断中的价值。方法 :采用改良DEAESephadexA50 离子交换柱层析法、PGGT单抗Elisa间接混合夹心法、RT PCR等方法对 14 2例黄疸患者血清PGGT、TGGT及组织中GGTmRNA的表达进行研究。... 目的 :探讨PGGT、PGGT单克隆抗体和GGTmRNA表达在胰头癌诊断中的价值。方法 :采用改良DEAESephadexA50 离子交换柱层析法、PGGT单抗Elisa间接混合夹心法、RT PCR等方法对 14 2例黄疸患者血清PGGT、TGGT及组织中GGTmRNA的表达进行研究。结果 :以血清PGGT >4U/L、PGGT/TGGT >0 .1作为诊断胰头癌的指标 ,其阳性率为 6 2 .5 %。PGGT单克隆抗体检测血清中PGGT恶性阻塞性黄疸及胰头癌阳性率分别为 5 9.0 %及 10 0 %。通过RT PCR法检测GGTmRNA的相对表达量 ,胰头癌组 (占 6 2 .5 % ) >胆管癌组(占 35 .8% ) >正常组 (占 2 9.4 % )。结论 :PGGT、PGGT/TGGT、PGGT单克隆抗体及GGTmRNA表达在梗阻性黄疸鉴别诊断中有其重要意义 ,有望成为诊断胰头癌的方法。 展开更多
关键词 胰腺肿瘤 基因γ-谷氨酰转移酶 抗体 单克隆 聚合酶链反应
下载PDF
半乳糖抗小鼠CD_3单抗作为肝癌术后免疫治疗载体的研究 被引量:3
16
作者 李云春 管昌田 +3 位作者 杨晓川 何生 蒋平 袁霖 《中华核医学杂志》 CAS CSCD 北大核心 2000年第5期193-196,I007,共5页
目的 探讨利用放射性核素示踪技术研究半乳糖抗小鼠CD3 单克隆抗体 (Gal Ant CD3McAb)作为原发性肝癌 (PLC)术后免疫治疗载体的可行性。方法 以半乳糖 (Gal)为原料 ,制得 2 亚氨基 2 甲氧乙基 1 硫代 β D 半乳糖苷 (IME) ,与抗小... 目的 探讨利用放射性核素示踪技术研究半乳糖抗小鼠CD3 单克隆抗体 (Gal Ant CD3McAb)作为原发性肝癌 (PLC)术后免疫治疗载体的可行性。方法 以半乳糖 (Gal)为原料 ,制得 2 亚氨基 2 甲氧乙基 1 硫代 β D 半乳糖苷 (IME) ,与抗小鼠CD3 单克隆抗体 (Ant CD3 McAb)共价偶联制得Gal Ant CD3 McAb ,再用1 3 1 I或1 2 5 I标记Gal Ant CD3 McAb和Ant CD3 McAb ,通过小鼠体内分布实验和家兔显像实验 ,对比研究两者肝化差异 ;将Gal Ant CD3 McAb与肿瘤浸润淋巴细胞 (TIL)联接制得Gal Ant CD3 McAb TIL ,研究其体外趋肝性和杀伤自体肿瘤细胞作用。结果 Gal Ant CD3 McAb具有明显的趋肝性 ,每克肝组织最大摄取率为注入量的 (5 9 0± 2 1) % ,是Ant CD3 McAb的 2倍以上 ;Gal Ant CD3 McAb TIL在体外有良好的趋肝性 ,且杀伤自体肿瘤细胞的作用极强。结论 Gal Ant 展开更多
关键词 肝癌 放射免疫疗法 单克隆抗体 术后 实验研究
下载PDF
Fas转染及抗体处理对舌鳞癌细胞Tca8113移植瘤形成和增殖的影响 被引量:3
17
作者 侯劲松 黄洪章 +1 位作者 王建广 潘朝斌 《华西口腔医学杂志》 CAS CSCD 北大核心 2004年第3期189-191,197,共4页
目的 研究Fas转染和抗Fas单克隆抗体对舌鳞癌细胞系Tca8113裸鼠体内移植瘤形成和增殖的影响 ,探讨相关机制。方法 脂质体法以真核表达重组质粒pBK_fas转染舌鳞癌细胞系Tca8113。部分转染细胞行抗Fas单克隆抗体处理。未转染细胞、Fas... 目的 研究Fas转染和抗Fas单克隆抗体对舌鳞癌细胞系Tca8113裸鼠体内移植瘤形成和增殖的影响 ,探讨相关机制。方法 脂质体法以真核表达重组质粒pBK_fas转染舌鳞癌细胞系Tca8113。部分转染细胞行抗Fas单克隆抗体处理。未转染细胞、Fas转染细胞、Fas转染抗体处理细胞分别接种裸鼠皮下。观测移植瘤生长 ,绘制生长曲线。RT_PCR检测肿瘤细胞FasmRNA表达。流式细胞术 (FCM)检测肿瘤细胞凋亡、增殖及Fas蛋白表达。结果 Fas转染和抗体处理延迟肿瘤形成 ,抑制肿瘤增殖。Fas转染上调移植瘤FasmRNA表达 ,提高Fas蛋白表达强度和凋亡指数 ,但不影响Fas蛋白阳性表达率和增殖指数。抗体处理不影响FasmRNA和蛋白表达 ,但可提高凋亡指数 ,降低增殖指数。结论 Fas转染抑瘤效应是上调Fas转录和表达、促进凋亡的结果。抗Fas单克隆抗体抑瘤效应则与激活凋亡和抑制增殖有关。 展开更多
关键词 FAS 基因转染 抗Fas单克隆抗体 舌鳞状细胞癌 基因治疗
下载PDF
蝎毒多肽提取物对人膀胱癌T24细胞增殖抑制作用的研究 被引量:7
18
作者 侯毅 龙俊任 +3 位作者 张平 龙兵 陈晓波 董自强 《天津医药》 CAS 北大核心 2013年第3期204-207,共4页
目的探讨蝎毒多肽提取物(PESV)对人膀胱癌T24细胞增殖的抑制作用及其机制。方法采用体外培养法培养T24细胞,应用MTT法检测对照组和实验组(不同浓度PESV)处理膀胱癌T24细胞后的增殖变化;倒置显微镜观察其对T24细胞形态的影响;RT-PCR检测... 目的探讨蝎毒多肽提取物(PESV)对人膀胱癌T24细胞增殖的抑制作用及其机制。方法采用体外培养法培养T24细胞,应用MTT法检测对照组和实验组(不同浓度PESV)处理膀胱癌T24细胞后的增殖变化;倒置显微镜观察其对T24细胞形态的影响;RT-PCR检测实验组(低剂量、中剂量及高剂量)BAX和Bcl-2的mRNA的表达变化。结果:PESV能显著抑制T24细胞的增殖,呈现时间和剂量依赖性,差异具有统计学意义(P<0.01),24h抑制率接近50%的T24细胞生长浓度为75mg/L;低、中及高浓度PESV均可致T24细胞生长明显抑制,出现典型细胞凋亡形态;和对照组比较,实验组BAXmRNA和BAX/Bcl-2mRNA表达升高,Bcl-2mRNA表达下降,差异有统计学意义(P<0.01)。结论 PESV对膀胱癌T24细胞具有明显抑制作用,其诱导T24细胞凋亡的作用可能与上调BAX和下调Bcl-2的表达有关。 展开更多
关键词 膀胱肿瘤 细胞系 肿瘤 细胞凋亡 基因 bcl-2 BCL-2相关X蛋白质 蝎毒多肽提取物
下载PDF
膀胱移行细胞癌RASSF1A和Cyclin D1与Bcl-2蛋白的表达及意义 被引量:2
19
作者 钟凯华 柳建军 +3 位作者 曹军 黄裕清 余自强 张云山 《中华肿瘤防治杂志》 CAS 2007年第21期1632-1635,共4页
目的:探讨RASSF1A、CyclinD1和Bcl-2蛋白在膀胱移行细胞癌发生发展中的作用,以及RASSF1A和CyclinD1与Bcl-2蛋白之间的关系。方法:免疫组化法(SP法)检测45例膀胱移行细胞癌组织、45例癌旁黏膜及18例正常黏膜组织中RASSF1A、CyclinD1和Bc... 目的:探讨RASSF1A、CyclinD1和Bcl-2蛋白在膀胱移行细胞癌发生发展中的作用,以及RASSF1A和CyclinD1与Bcl-2蛋白之间的关系。方法:免疫组化法(SP法)检测45例膀胱移行细胞癌组织、45例癌旁黏膜及18例正常黏膜组织中RASSF1A、CyclinD1和Bcl-2蛋白的表达。结果:膀胱移行细胞癌组织中RASSF1A、CyclinD1和Bcl-2蛋白表达阳性率分别为46.7%(21/45)、88.9%(40/45)和57.8%(26/45);癌旁组织分别为84.4%(38/45)、42.2%(19/45)和24.4%(11/45);正常组织分别为94.4%(17/18)、38.9%(7/18)和16.7%(3/18)。膀胱移行细胞癌组织中RASSF1A蛋白的表达显著低于癌旁及正常膀胱黏膜,P<0.05;而CyclinD1和Bcl-2蛋白的表达则显著升高,P<0.05。RASSF1A和CyclinD1及Bcl-2蛋白的表达呈负相关性,P<0.05。结论:RASSF1A蛋白的表达降低和CyclinD1、Bcl-2蛋白的过表达可能参与膀胱移行细胞癌的发生发展过程,RASSF1A可能通过某种机制促使CyclinD1和Bcl-2在膀胱移行细胞癌中过表达,从而促进膀胱移行细胞癌的发生发展。 展开更多
关键词 移行细胞/病理学 膀胱肿瘤/病理学 基因表达 免疫组织化学
下载PDF
抗人卵巢癌单克隆抗体COC183-B_2重链可变区基因的体外扩增、克隆及序列分析 被引量:6
20
作者 周萍 冯捷 +1 位作者 蒋欣 黄华梁 《北京医科大学学报》 CSCD 1998年第3期202-204,共3页
目的:分离抗人卵巢癌单克隆抗体COC183B2重链可变区(VH)基因并测定其序列。方法:用反转录PCR扩增抗人卵巢癌单抗COC183B2VH基因,将其克隆入PUC19载体,重组子用Sanger’s双脱氧链终止法... 目的:分离抗人卵巢癌单克隆抗体COC183B2重链可变区(VH)基因并测定其序列。方法:用反转录PCR扩增抗人卵巢癌单抗COC183B2VH基因,将其克隆入PUC19载体,重组子用Sanger’s双脱氧链终止法测定序列,将序列与GeneBank及已发表的抗体序列比较。结果:VH基因全长354bp,属鼠免疫球蛋白重链混杂亚类(subgroupmiscelaneous),由种系基因的VH,Dsp2.5及MUSJH4重排而来。该VH基因序列已被GeneBank收录(accessionNoAF045023)。结论:该VH基因为抗人卵巢癌单抗COC183B2功能性重链可变区基因。 展开更多
关键词 卵巢肿瘤 单克隆抗体 基因扩增 序列分析
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部